Building a network of strategic partnerships and a core team with industry expertise.
Dennis Petke, CA
CEO, President and Director
Dennis Petke, CA – CEO, President and Director
Mr. Petke is a qualified Chartered Accountant in Canada, and has been a member of the Institute of Chartered Accountants of British Columbia since 1995. Currently serving as a director and/or senior officer for private and public companies, his responsibilities include strategic and overall corporate management for these companies. Mr. Petke has accumulated extensive experience in the area of corporate finance, including negotiating and implementing private and public company mergers, as well as facilitating private placement, preference share, convertible debenture, special warrant and debt financings.
Harvey Lawson has had many years of experience in the management of public companies. He served as CFO of Trade Winds Ventures in 2001 until the company was purchased by Detour Gold Corp. on 2011. Prior to this, Harvey taught Financial Management at the National University of Singapore, Hong Kong Polytechnic, and the BC Institute of Technology. Harvey also mentors many young entrepreneurs in the technology sector and is an active member of several Angel Investor groups in the Pacific Northwest where he reviews the financials of presenting companies, including due diligence processes, for companies applying for investment.
Rupert Shore has been a barrister and solicitor in good standing with the Law Society of British Columbia since November 1989. Prior to this, Mr. Shore attended the University of Victoria, obtaining a Bachelor of Arts majoring in Geography Resource Management and a Bachelor in Laws. After graduation he served as a clerk to the Judges of the Vancouver County Court and has practiced law as a sole practitioner primarily in commercial litigation. He has made it his goal to resolve legal issues for clients in the most cost-effective manner possible as litigation is expensive and difficult to predict.
Sina Pirooz is a registered and practicing pharmacist, and a professional member of the College of Pharmacists of British Columbia since 2002 with over ten years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over ten years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz will be assisting Alliance with certain product development with his expertise in compounding, sales, marketing and export of pharmaceuticals.
Ian Lambert holds a Bachelor of Commerce degree in quantitative analysis and computer science from the University of Saskatchewan. His strengths are in corporate management, structuring and strategic planning, regulatory compliance with both the SEC and Canadian regulatory authorities, public financing arrangements and investor and institutional marketing activities. Familiar with a wide range of business activities including marketing, manufacturing and technology development, Mr. Lambert gives a wide insight into what can be expected moving forward. He is currently a director, officer and/or advisor to several Canadian companies in addition to serving as management of a variety of public interests, and has acted as Chair of various corporate committees.
Regulatory and Financial Advisor
Charles Rendina is an international business lawyer, licensed to practice law in Washington and British Columbia, with over 26 years of experience. Mr. Rendina’s background includes work as a licensed financial advisor for a large U.S. broker/dealer and, more recently, a partner in Seedfundr.com, one of the first business crowdfunding platforms in British Columbia. He is currently the owner of Rendina Law Firm and a principal of Fourwall Solutions LLP, a real estate development partnership, and a managing partner in Opportunity Northwest LLC., which provides services typically to early mid-stage companies often considering relocation or expansion into the USA from Canada or other out-of-state locations.
Edmund Obasi has over a decade of relevant business experience, specializing in public companies business financing, private placements and medical marijuana related investments. Mr. Obasi is currently serving as the Chief Executive Officer, Chief Investment Officer and Director of OBASI INVESTMENT LIMITED, a private investment company registered in Alberta Canada. Edmund completed his Master’s Degree in Applied Mathematics from the University of Waterloo Ontario and his diversified experiences to a wide range of business activities include oil and gas, mining, real estate, cannabis and related products. Over the past several years, Mr. Obasi has been focusing extensively on research and investments in cannabis related public companies and the cannabis sector.
Biotechnology and Government Relations Advisor
Mr. Carveth has been the President of Consilium Enterprises Inc. since 2002, connecting innovative technology, finance, and management for clients in Canada, United States, and Mexico. He has international business experience as the Director of Mexican Affairs for the Pacific Seafood Group, and as Business Development Advisor to Power Air Canada Corporation. Robert will act as the Biotechnology and Government Relations Advisor to Alliance, bringing his expertise in provincial, national, and international government, structure, function, processes, regulatory, and relations matters as well as experience in early stage technology companies, university research and development, intellectual property, commercialization and licensing.
Pharmagreen is a biotech sciences company with specialized products and services in the cannabis industry. The company is currently in the Licensed Producer application process with Health Canada for its Cannabis Botany Center in Deroche, B.C. Services attributed to Pharmagreen will include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. Pharmagreen future brand of products will focus on manufacturing and marketing of Cannabis products for medical and recreational markets in Canada with an eye on International markets.
Canwe believes that Canadians deserve access to the best products at fair and affordable prices. Canwe aims to set the bar high by growing premium strains of clean, high-quality cannabis that patients can depend on. Their planned hydroponic growing system is designed with safety and efficiency in mind. With designs that include the use of robotics and smart sensors, we aim to minimize the need for human interference. This helps reduce the risk of contamination and results in a quality-controlled environment able to produce clean, healthy cannabis plants from one crop to the next.
Mont-Royal, Québec, Canada
Biocannatech is to become a licensed producer under Health Canada’s Cannabis Regulations. The company has a leased a 10,000 square foot facility in Mont-Royal, and an adjacent facility 17,900 square foot facility as part of the application process.
OTCQB Symbol ALGWF
1 Private placement opportunity providing the best value in booming cannabis sector
2 Cannabis Biotech Complex to be developed in Deroche, BC for production of plantlets to be distributed to licensed producers.
3 Strategic investments
in Licensed Producer applicants that leads to long term tissue culture supply contracts.
4 $ 4 million equity facility
in a series of private placements at progressively higher prices via a New York Family Office
5 Significant Gains in Strategic Investments in the Cannabis space.
6 Licensed research and Development with B.R.I.M. and the Chibafreen Process
B.R.I.M. is a privately held research and development company focused on the cannabis industry. Developer of “Chibafreen” invitro plant micro propagation proprietary technology for the production of tissue cultures for exclusive use in the Pharmagreen’s Cannabis Botany Center. The company has also been developing for the last three years tissue culture protocols for variety of cannabis strains. In particular it has developed a hemp strain with a high CBD, very low THC content dubbed as “CBD Dana” for the medical cannabis market and industrial scale hemp production. Pharmagreen’s Cannabis Botany Center is the exclusive supplier of “CBD Dana” plantlets. Future research and development will be for the cannabis oils extracts formulations for humans to be produced and branded by Pharmagreen. B.R.I.M. will use SSR marker (Simple sequence repeat) technology to fingerprint varieties. We will develop an extensive database for several crops. These services will provided by B.R.I.M. as a value added service for Pharmagreen’s Botany Center. The company is currently in application process with Health Canada for the Dealer Licence.